Overview

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Status:
Recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
This trial will evaluate whether empirical treatment against cytomegalovirus and tuberculosis improves survival of HIV-infected infants with severe pneumonia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hospital Universitario 12 de Octubre
Collaborators:
Barcelona Institute for Global Health
Centre Hospitalier Cocody
Centro de Investigação em Saúde de Manhiça
Eduardo Mondlane University
Institut National de la Santé Et de la Recherche Médicale, France
Makerere University
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
PENTA Foundation
Stichting Katholieke Universiteit
University Hospital, Bordeaux
University of Lincoln
University of Zimbabwe
University Teaching Hospital, Lusaka, Zambia
Treatments:
Antitubercular Agents
Valganciclovir